Results 21 to 30 of about 49,735 (302)

Intravenous immunoglobulin G (IVIg): Properties of dimeric and sialylated IgG [PDF]

, 2013
This thesis describes the properties of the IgG dimer and sialylated IgG fraction in IVIg. Both fractions have been suggested to contribute to the immune modulating effects of IVIg in the treatment of autoimmune and inflammatory diseases.
Guhr, T.
core   +21 more sources

Study on the Treatment of ITP Mice with IVIG Sourced from Distinct Sex-Special Plasma (DSP-IVIG)

, 2023
Intravenous immunoglobulin (IVIG) is a first-line drug prepared from human plasma for the treatment of autoimmune diseases (AIDs), especially immune thrombocytopenia (ITP). Significant differences exist in protein types and expression levels between male
Shengliang Ye, Wei Zhang, Changqing Li, Zongkui Wang, Fengjuan Liu, Rong Zhang, Xi Du, Li Ma, Fangzhao Lin, Xin Yuan, Jixuan Xu, Peng Jiang   +11 more
core   +1 more source

Enhanced Pro-apoptotic Effects of Fe(II)-Modified IVIG on Human Neutrophils [PDF]

, 2020
International audienceMild modification of intravenous immunoglobulin (IVIG) has been reported to result in enhanced polyspecificity and leveraged therapeutic effects in animal models of inflammation.
Dimitrov, Jordan,, Schneider, Christoph, Cummings, Richard,, Yawalkar, Nikhil, Seibold, Frank, Vassilev, Tchavdar, Dimitrov, Jordan, D, Smith, David F, Simon, Hans-Uwe, Villiger, Peter, Smith, David, F, Cummings, Richard D, Verschoor, Daniëlle, Graeter, Stefanie, Cummings, Richard, D, Dimitrov, Jordan D, Smith, David,, von Gunten, Stephan, von Däniken, Sandro   +18 more
core   +2 more sources

Relative EBV antibody concentrations and cost of standard IVIG and CMV‐IVIG for PTLD prophylaxis in solid organ transplant patients [PDF]

, 2014
Some centers prefer CMV-IVIG over IVIG for the prophylaxis of EBV-related PTLD in solid organ transplant patients. Our objective was to compare the relative dose-related EBV ELISA antibody concentrations and cost of standard IVIG and CMV-IVIG.
Ramirez‐Avila, L, Garner, OB, Cherry, JD   +2 more
core   +1 more source

Effect of IgG dimer concentration on the binding ability of IgG Fc fragment in IVIG to THP-1 cell surface receptors

Zhongguo shuxue zazhi, 2023
Objective To investigate the effect of immunoglobulin G (IgG) dimer concentration of intravenous immunoglobulin (IVIG) on the binding ability of IgG Fc fragment to THP-1 cell surface receptors.
Tingting LEI, Wei ZHANG, Changqing LI, Shengliang YE, Xi DU, Li MA   +5 more
doaj   +1 more source

Older Adults and Immune Thrombocytopenia: Considerations for the Clinician

Clinical Interventions in Aging, 2023
Etienne Crickx,1,2 Matthieu Mahévas,1,3,4 Marc Michel,1 Bertrand Godeau1 1Service de Médecine Interne, Centre national de référence des cytopénies auto-immunes de l’adulte, Hôpital Henri Mondor, Fédération Hospitalo-Universitaire TRUE InnovaTive theRapy ...
Crickx E, Mahévas M, Michel M, Godeau B
doaj  

Intravenous immunoglobulin suppresses the polarization of both classically and alternatively activated macrophages

Human Vaccines & Immunotherapeutics, 2020
Intravenous immunoglobulin (IVIG) is one of the widely used immunotherapeutic molecules in the therapy of autoimmune and inflammatory diseases. Previous reports demonstrate that one of the anti-inflammatory actions of IVIG implicates suppression of ...
Chaitrali Saha, Prathap Kothapalli, Veerupaxagouda Patil, Gundallahalli Bayyappa ManjunathaReddy, Srini V Kaveri, Jagadeesh Bayry   +5 more
doaj   +1 more source

Impact of the COVID-19 pandemic on the frequency, clinical spectrum and outcomes of pediatric guillain-Barré syndrome in India: A multicentric ambispective cohort study

Annals of Indian Academy of Neurology, 2022
Objective: To study impact of COVID-19 pandemic on frequency, clinical/electrophysiological profile and treatment outcomes in pediatric Guillain-Barré syndrome (GBS). Background: GBS is the most frequent cause of pediatric acute flaccid paralysis.
Divyani Garg, Rajinder K Dhamija, Aditya Choudhary, Ritu Shree, Sujit Kumar, Priyanka Samal, Abhishek Pathak, Pamidimukkala Vijaya, Yareeda Sireesha, Sruthi S Nair, Sanjay Sharma, Soaham Desai, Human P Sinha, Ayush Agarwal, Ashish Upadhyay, M V Padma Srivastava, Rohit Bhatia, Awadh K Pandit, Rajesh K Singh, Alisha Reyaz, P M Yogeesh, Manish Salunkhe, Vivek Lal, Manish Modi, Gagandeep Singh, Monika Singla, Samhita Panda, Maya Gopalakrishnan, Inder Puri, Sudhir Sharma, Bismay Kumar, Prashant K Kushwaha, Harshadkumar Chovatiya, Teresa Ferreira, Sanjeev K Bhoi, Manish Bhartiya, Subhash Kaul, Anuja Patil, Neeharika L Mathukumalli, Madhu Nagappa, P Praveen Sharma, Aneesh Basheer, Dileep Ramachandran, Neetha Balaram, Jospeh Sebastian, Venugopalan Y Vishnu, on behalf of the GBS consortium   +46 more
doaj   +1 more source

IVIg dose increase in multifocal motor neuropathy: a prospective six month follow-up [PDF]

, 2009
In this prospective, non-randomized 6-month observational study we evaluated the efficacy of intravenous immunoglobulin (IVIg) dose increase in patients with multifocal motor neuropathy (MMN).
Hess, Christian W, Sturzenegger, Matthias, Baumann, Andreas   +2 more
core   +2 more sources

The use of IVIG in neurological disease [PDF]

Clinical Reviews in Allergy, 1992
The studies cited herein highlight the potential benefits of IVIG therapy in a group of neurological disorders that are associated with aberrant immune responses. Indeed, all of the disorders discussed, except epilepsy, are associated with autoreactivity.
openaire   +2 more sources